Bioceltix SA (XI3) Stock Price & News

All values in PLN	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-
Cost of goods sold	501.09K	536.06K	533.98K	1.07M
Cost of revenue	501.09K	536.06K	533.98K	1.07M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.85M	3.67M	3.86M	4.62M
Operating expense	3.20M	3.91M	2.88M	4.70M
Total operating expenses	3.70M	4.45M	3.42M	5.77M
Operating income	-3.70M	-4.45M	-3.42M	-5.77M
Other non operating income	-	-	-	-
EBT including unusual items	-3.73M	-4.42M	-3.39M	-5.68M
EBT excluding unusual items	-3.73M	-4.42M	-3.39M	-5.68M
Income tax expense	5.56K	-40.40K	516.00	-6.97K
Effective tax rate	-0.15%	0.91%	-0.02%	0.12%
Other operating expenses	173.25K	82.21K	-1.14M	-80.02K
Net income	-3.74M	-4.38M	-3.39M	-5.68M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	74.80K	73.53K	50.46K	136.82K
Interest expense	-43.96K	-34.87K	-22.48K	-17.11K
Net interest expenses	30.83K	38.67K	27.98K	119.71K
Depreciation and amortization charges	174.36K	160.78K	161.63K	161.65K
EBITDA	-3.52M	-4.29M	-3.25M	-5.61M
Gain or loss from assets sale	-	-	-	-

Finance